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Among patients with decompensated cirrhosis, hospital
readmissions are common, costly, partially preventable, and
independently associated with mortality.1 This review will
discuss the scope of the problem, emphasize why clinicians
should care about this problem, and describe potential solu-
tions that can be readily implemented in clinical practice.
Scope of the Problem
In all disease states, early hospital readmissions are
increasingly being viewed as a public health threat. Among
the Medicare population, 19% of those discharged from an
acute-care hospital are readmitted within 1 month, at a cost
of> $17 billion, which represents nearly 20% of the Medi-
care budget.2 Patients discharged after a hospitalization for
decompensated cirrhosis have an even higher rate of early
readmission, at 20% to 37% within the first month (see Fig.
1). These readmissions are associated with an increased risk
of subsequent mortality, despite adjustment for other risk
factors such as severity of liver disease.1,3
Why Should Clinicians Care?
If these readmissions were entirely due to disease exac-
erbations, they would not garner nearly the attention they
have. On the contrary, an extensive body of literature has
demonstrated that many of these readmissions are avoid-
able. The discharge process is a time of extreme vulner-
ability to medical errors; new diagnoses have arisen, new
medications are being prescribed, and management of the
patient is being transitioned from one group of providers
to another. Unfortunately, significant deficits exist in
patient education and communication from inpatient to
outpatient providers. In various studies, these deficits are
felt to account for anywhere from 9% to 48% of readmis-
sions.4 In our study on cirrhosis readmissions, consensus
from independent reviewers attributed 22% of readmis-
sions to errors such as inadequate patient education
about medication dosing (especially how to adjust lactu-
lose) or lack of prompt follow-up labs or clinic visit to
adjust diuretics.1 Table 1 shows common preventable rea-
sons for cirrhosis readmissions, along with potential
solutions.
Not only should every clinician want to prevent avoid-
able readmissions, but there are increasing regulatory and
financial incentives to care about this problem. The Cen-
ters for Medicare and Medicaid Services Readmission
Reduction program currently penalizes hospitals with
higher than expected readmissions for myocardial infarc-
tion, heart failure, and pneumonia; this is likely to expand
to all readmissions in the near future. Following this lead,
some private insurers are scrutinizing early readmissions
and reimbursing the second stay as an extension of the
first, which cuts into the hospital profit. Additionally, the
advent of Accountable Care Organizations and other risk-
based insurance contracts means that any unnecessary
costs incurred by patients in these plans will be shared by
the hospital and clinicians. Early readmissions for cirrhosis
are quite expensive—direct costs average $25,000 for these
hospitalizations at our institutions (2009 dollars).1 This
means that clinicians interested in preventing readmissions
may find their hospital administrators to be willing and
eager partners.
Interventions to Decrease Readmissions
More than 50 randomized trials have tested various inter-
ventions, mostly in elderly patients with heart failure, with
mixed results.5 Synthesis of this literature is complicated by
bundling of interventions and heterogeneity between studies
in the patient populations, methods of implementation, and
local health care environment. Only one small pilot study
has been done in patients with cirrhosis.6 Although more
research certainly is needed, this does not prevent clinicians
from making small changes to their practice to improve care
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right now. Several important lessons can be gleaned from
the literature on readmissions.
Some of the simplest interventions also appear to be the
most effective. A recent systematic review identified a
pattern whereby the studies with positive benefit tended to
include two components: Patient-Centered Discharge
Instructions (PCDI) and an early postdischarge telephone
call or clinic visit.5 PCDI means simply providing discharge
instructions in a patient-friendly and readable format. Most
discharge summaries are bloated documents with extensive
medical jargon, serving more as an exhaustive accounting of
the hospital stay rather than a communication tool. The
PCDI, or After Hospital Care Plan, contains in large, read-
able format only the most important information for
patients to know, plus a follow-up plan with calendar and
‘‘patient activation’’ section to encourage patients to write
down questions for their next phone call or visit. An early
postdischarge telephone call occurs within 72 hours, and
reviews patients’ health status, medications, appointments,
home services, and plan for what to do if problems arise.
These calls should be made by someone involved in the
patient’s care in the hospital, the outpatient clinic, or both
(called a ‘‘transition provider’’); and reimbursement for these
calls is provided by many insurers in the form of transac-
tion codes. Detailed instructions about how to implement
the PCDI and postdischarge telephone calls are available
from the Agency for Healthcare Research and Quality-
funded Project RED Toolkit at http://www.bu.edu/fammed/
projectred/toolkit.html. Another toolkit based on similar
themes is available from the Care Transitions Program at
http://www.caretransitions.org/.
Implementation is just as important as the interventio-
n. Unlike a pill, effectiveness of these interventions is sig-
nificantly influenced by the person who delivers them, as
well as the local health care environment. A glossy, color-
ful and easily readable PCDI packet will be only margin-
ally effective if it is simply dropped in the patient’s lap.
Instead, these instructions need to be carefully reviewed
with the patient and the family caregiver, and the impor-
tance of the PCDI needs to be reinforced by the outpatient
providers. At our institution, for example, patients are
instructed to bring their Cirrhosis Toolkit to every visit; if
they show up to the clinic empty-handed, then we remind
them.7 Similarly, the postdischarge telephone calls need to
Figure 1 Time to first readmission among patients with decomensated cir-
rhosis. Reproduced from Volk et al.1.
TABLE 1 Common Preventable Reasons for Early Readmission Among Patients With Decompensated Cirrhosis, Along With Potential Solutions
Deficit Goal Intervention(s)
Patient stops having bowel movements, yet fails to







Patient takes incorrect dose of diuretics, leading
to readmission for under- or over-diuresis.
Improve patient/caregiver
knowledge about medications and dosing




Medication reconciliation at outpatient clinic.
Patient waits until ascites is severe before calling,
leading to admission for urgent paracentesis.
Improve patient/caregiver
knowledge about when and where to call.
PCDI
Postdischarge telephone call.
Accessible phone triage system in outpatient
clinic.
Patient is discharged on increased dose of diu-
retics, then presents to the ER with
overdiuresis.
Improve postdischarge monitoring. PCDI with clear instructions for follow-up labs or
clinic visit.
Postdischarge telephone callHome health referral.
Patient has slow bleeding from portal hypertensive
gastropathy or GAVE, and presents to the ER
with symptomatic anemia.
Improve postdischarge monitoring. PCDI with clear instructions for follow-up labs or
clinic visit.
Post-discharge telephone callHome health referral.
ER5 emergency room; GAVE5 gastric antral vascular ectasia; PCDI5 patient-centered discharge instructions.
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be made by an experienced nurse educator trained in tech-
niques to facilitate patient understanding, such as the
‘‘teach-back’’ method.8
Preventing readmissions is a continuous process. Local
healthcare environments vary significantly, so an intervention
proven in one setting may need to be modified to apply to
another. For this reason, readmission interventions are often
mini-experiments: It is not practical to conduct a randomized
trial for each change, so follow-up is needed to determine
whether the change worked as intended. This is the basis
behind the ‘‘Plan-Do-Study-Adjust’’ cycle of quality improve-
ment popularized by W. Edwards Deming.9 In order to deter-
mine effectiveness, it is helpful to measure not only hospital
readmissions over time, but also intermediate endpoints such
as patient understanding of their discharge instructions. Sec-
ond, clinical medicine changes: What was appropriate care
one year may be outdated the next. Third, the individuals in
an organization change, and ‘‘institutional memory’’ about
process changes can wane over time. Finally, a continuous
effort to prevent readmissions makes this problem an appro-
priate focus of emphasis in the organizational culture.
Summary
Preventable hospital readmissions are common among
patients with decompensated cirrhosis. Not only are they
harmful to patients, they also negatively impact the financial
margin for hospitals and clinicians. In the future, advanced
technology will likely be used to improve patient education
and in-home monitoring.10,11 For now, however, clinicians
can help prevent readmissions with simple interventions
such as PCDIs and early postdischarge telephone calls.
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